Vanessa Jeske

Vanessa Jeske

Human Resources Manager

Vanessa brings over 15 years of HR experience gained from working for local, national and multinational organisations.

Working in industry sectors such as training and education, energy and engineering, professional services, manufacturing and aerospace, Vanessa has filled specialist and generalist roles, HR management and organisational development roles delivering performance improvement, organisational development and leadership solutions.


Contact:

+61 (07) 3365 4037
v.jeske@uniquest.com.au


Jenny Randall

Jenny Randall

CPA
Financial Controller

Jenny is an experienced accountant with more than 30 years in financial management experience.

She has been with UniQuest for 25 years and was appointed Financial Controller in 2000.

Jenny holds a Bachelor of Business, and is a Certified Practising Accountant.

Contact:

+61 (07) 3365 4037
j.randall@uniquest.com.au


Jane Malloch

Jane Malloch

BA LLB
General Counsel

Jane joined UniQuest in July 2017 after leading The University of Queensland (UQ) Research Legal team for more than a decade, providing expert legal advice and solutions to the UQ research community and support for university commercialisation.

She has extensive experience in commercial negotiations and agreements. Prior to UQ, Jane was a University of Technology Sydney Senior University Lawyer and the Director of Legal Services at Griffith University.

Before entering the higher education sector, she was a Commercial Officer for Nabalco (now Rio Tinto ALCAN Gove)  and gained broad-based legal experience with an emphasis on litigation in private law firms in Sydney and New Zealand.

Contact:

+61 (07) 3365 4037
j.malloch@uniquest.com.au


Dean Moss

Dr Dean Moss

BSc, MPhil, PhD (UQ), GAICD
Chief Executive Officer

Dean is CEO of UniQuest, Australia’s leading university commercialisation entity, managing the intellectual property of The University of Queensland.

Dean has more than 30 years’ experience in science, academia, business, management and commercialisation in Australia, the US and the UK.

He has been managing director or senior business development executive of several health and biotech companies worldwide, including Agen Biomedical, Launch Diagnostics, AMRAD ICT, AMRAD Biotech, and United Drug. Dean established the highly-successful York Medical Technologies as a start-up in the UK in 2004.

He is a board member of several Australian biotechnology companies and was a member of the investment committee of the pre-seed venture funds Uniseed, the Medical Research Commercialisation Fund and the New Zealand Government’s KiwiNet.

Throughout his career, Dean has managed the raising of more than $100M in venture capital investment.

He sits on the NHMRC Health Innovation Advisory Committee and is Chair of the Go8 Innovation and Commercialisation Group. In 2018, Dr Moss was awarded the title of Adjunct Professor in the Office of the UQ’s Deputy Vice-Chancellor (Research).

Contact:

+61 (07) 3365 4037
d.moss@uniquest.com.au


Mark Ashton

Dr Mark Ashton

BSc (Hons), PhD
Executive Director, IP Commercialisation

Mark joined UniQuest in 2010 and is currently the Executive Director of Intellectual Property Commercialisation. Prior to this he was the Manager of Innovation and Commercial Development for The Institute for Molecular Bioscience and Health Sciences at The University of Queensland.

Before joining UniQuest, Mark was the Executive Vice President, Business Development at the international biotech, Evotec AG, a company that focuses on drug discovery alliances and development partnerships with the pharmaceutical and biotech industry.  Prior to leading the business development group at Evotec, he was President, Discovery Services at Evotec, responsible for the company’s Drug Discovery division, a division that carried out projects involving high throughput screening, parallel synthesis and medicinal chemistry to pre-clinical development.

Mark has worked within the biotech and pharmaceutical industry since the early 1990s and has both operational and commercial experience of a wide range of life science projects. He has worked with most of the major pharmaceutical companies and a number of biotech companies around the world, negotiating agreements totalling more than $100 million.

Mark is the author and co-author of a number of peer reviewed scientific publications and patents including new chemical entities that have progressed to human clinical trials. He has a PhD in chemistry having worked on a medicinal chemistry-focused project sponsored by an international pharmaceutical company.

Contact:

+61 (07) 3365 4037
m.ashton@uniquest.com.au